IP Library Granted Patent US 9,273,065
Granted Patent B2
US 9,273,065 · App. 14/700,679 · Granted Mar 1, 2016

Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors

Inventors: Brian A. Johns (Research Triangle Park, NC); Takashi Kawasuji (Osaka, JP); Teruhiko Taishi (Osaka, JP); Yoshiyuki Taoda (Osaka, JP)
Assignees: Shionogi & Co., Ltd.; ViiV Healthcare Company
C07D498/14C07D471/04C07D471/14C07D471/22C07D498/04C07D498/20C07D498/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,273,065
App. No.
14/700,679
Granted
Mar 1, 2016
Kind
B2
Abstract

The present invention is directed to a class of substituted pyrido[1′2′:4,5]pyrazino[1,2-a]-pyrimidines useful as intermediates in the production of anti-HIV agents. The compounds have the formula (I-24b): wherein R e is one or two halogen; R z is C 1-8 alkyl; R z is hydrogen, C 3-6 cycloalkyl, heterocyclyl, or C 1-8 alkyl optionally substituted with hydroxy, C 3-6 cycloalkyl, alkoxy, heterocyclyl, heteroaryl, C 6-14 aryl, or amino, wherein said amino may be optionally substituted with —C(O)C 1-8 alkyl or C 1-8 alkyl; and P 1 is C 6-14 arylC 1-8 alkyl; or a pharmaceutically acceptable salt thereof.

Claims (27)

1. A compound of formula (I-24b)

wherein:

R e is one or two halogen;

R z is C 1-8 alkyl;

R z1 is hydrogen, C 3-6 cycloalkyl, heterocyclyl, or C 1-8 alkyl optionally substituted with hydroxy, C 3-6 cycloalkyl, alkoxy, heterocyclyl, heteroaryl, C 6-14 aryl, or amino, wherein said amino may be optionally substituted with —C(O)C 1-8 alkyl or C 1-8 alkyl; and

P 1 is C 6-14 arylC 1-8 alkyl;

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein R e is one or two fluorine.

3. The compound of claim 1 , wherein R z is methyl.

4. The compound of claim 1 , wherein R z1 is C 3-6 cycloalkyl.

5. The compound of claim 1 , wherein R z1 is C 3 cycloalkyl.

6. A compound which is:

7. A process for the preparation of a compound of formula (I-24b)

wherein

R e is one or two halogen;

R z is C 1-8 alkyl;

R z1 is hydrogen, C 3-6 cycloalkyl, heterocyclyl, or C 1-8 alkyl optionally substituted with hydroxy, C 3-6 cycloalkyl, alkoxy, heterocyclyl, heteroaryl, C 6-14 aryl, or amino, wherein said amino may be optionally substituted with —C(O)C 1-8 alkyl or C 1-8 alkyl; and

P 1 is C 6-14 arylC 1-8 alkyl;

comprising condensing a compound of the formula

wherein R e is one or two halogen;

R 50 is C 1-8 alkyl; and

P 1 is C 6-14 arylC 1-8 alkyl;

with a compound of the formula

wherein

R z is C 1-8 alkyl;

R z1 is hydrogen, C 3-6 cycloalkyl, heterocyclyl, or C 1-8 alkyl optionally substituted with hydroxy, C 3-6 cycloalkyl, alkoxy, heterocyclyl, heteroaryl, C 6-14 aryl, or amino, wherein said amino may be optionally substituted with —C(O)C 1-8 alkyl or C 1-8 alkyl; to form a compound of the formula (I-24b).

8. The process of claim 7 , further comprising a step of replacing the C 6-14 arylC 1-8 alkyl of P 1 with hydrogen.

Priority Claims (2)
JP 2005-131161 · Apr 28, 2005 · national
JP 2005-312076 · Oct 27, 2005 · national
Continuity (5)
Division 14211364 · Mar 14, 2014
Division 13763174 · Feb 8, 2013
Division 13352686 · Jan 18, 2012
Division 11919386
Related Publication 20150232479A1 · Aug 20, 2015